Blood pressure drive-through: An innovative way to meet patient care needs during a pandemic

Thompson, Aleda; Vereecke, Amy; Bassett, Katherine; Trott, Frances; Mazer, Dale M.; Choe, Hae Mi

doi:10.1093/ajhp/zxac036

Cited by 3 publications

(2 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…(35) To improve the reach of screening efforts, clinic-community pharmacy partnerships and other outreach methods may also be needed to consistently monitor HbA1c and BP during times when in-person care options are limited. (14)(15)(16)36) Our results should be considered with some limitations. First, the 15-month activity window before each study period may have excluded established patients based on utilization prior to March of each year.…”

Section: Discussionmentioning

confidence: 94%

“…Some organizations also developed innovative ways to promote self-measured BP and improve access to BP screening during the pandemic, including using care team approaches and "drive-through" BP assessment in partnership with community pharmacies. (14)(15)(16)(17). Based on these observations, we hypothesized that blood pressure testing was maintained to a greater degree for adults with type II diabetes during the pandemic period compared to hypertension-only.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Telemedicine Use and Decrements to Type 2 Diabetes and Hypertension Care during the COVID-19 Pandemic

Rodríguez

Ciemins

Rubio

et al. 2023

Preprint

View full text Add to dashboard Cite

Background: We examine pandemic-era quality of care changes associated with telemedicine use among adults with type 2 diabetes and/or hypertension across ten health systems. Methods: Patient-level encounter and laboratory data (n=1,963,563) were analyzed for pre-pandemic (March 13, 2019 to December 31, 2019) and pandemic (March 13, 2020 to December 31, 2020) periods. Generalized linear models with binomial distribution functions and log links estimated the association of telemedicine use with four outcomes: 1) hemoglobin A1c (HbA1c) testing, 2) HbA1c control (<8.0%), 3) blood pressure (BP) testing, and 4) BP control (<140 / 90 mmHg), controlling for patient characteristics, system fixed effects, and with propensity score weights. Results: In adjusted analyses, telemedicine use was associated with lower odds of HbA1c (aOR=0.74, p<0.05) and BP (aOR=0.40, p<0.01) testing for adults with type 2 diabetes, but not HbA1c or BP control. Among hypertension-only patients, telemedicine use was associated with lower odds of BP testing (aOR=0.10, p<0.001), but not BP control. Compared to pre-pandemic telemedicine use, pandemic period telemedicine use was associated with lower odds of HbA1c and BP monitoring. Discussion: Telemedicine use was associated with lower odds of HbA1c monitoring for adults with type 2 diabetes and lower odds of BP testing for adults with type 2 diabetes and/or hypertension. Conclusion: As telemedicine continues to be used for diabetes and hypertension care, remote monitoring, standing orders, and community pharmacy partnerships may be necessary supplements to telemedicine to assure high quality care, especially when in-person care options are limited.

show abstract

Section: Discussionmentioning

confidence: 94%

mentioning

confidence: 99%

Telemedicine Use and Decrements to Type 2 Diabetes and Hypertension Care during the COVID-19 Pandemic

Rodríguez

Ciemins

Rubio

et al. 2023

Preprint

View full text Add to dashboard Cite

show abstract

Pandemic stimulates a variety of telepharmacy applications: Considerations for implementation, sustainability, and future directions

Miller¹,

Kane‐Gill

2022

American Journal of Health-System Pharmacy

View full text Add to dashboard Cite

Disclaimer In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.

show abstract

Telemedicine use and decrements to type 2 diabetes and hypertension care during the COVID-19 pandemic

Rodriguez,

Ciemins,

Rubio

et al. 2024

BMC Digit Health

View full text Add to dashboard Cite

Background We examine pandemic-era quality of care changes associated with telemedicine use among adults with type 2 diabetes and/or hypertension across ten health systems. Methods Patient-level encounter and laboratory data (n = 1,963,563) were analyzed for pre-pandemic (March 13, 2019 to December 31, 2019) and pandemic (March 13, 2020 to December 31, 2020) periods. Generalized linear models with binomial distribution functions and log links estimated the association of telemedicine use with four outcomes: 1) hemoglobin A1c (HbA1c) testing, 2) HbA1c control (< 8.0%), 3) blood pressure (BP) testing, and 4) BP control (< 140 / 90 mmHg), controlling for patient characteristics, system fixed effects, and with propensity score weights. Results In adjusted analyses, telemedicine use was associated with lower odds of HbA1c (aOR = 0.74, p < 0.05) and BP (aOR = 0.40, p < 0.01) testing for adults with type 2 diabetes, but not HbA1c or BP control. Among hypertension-only patients, telemedicine use was associated with lower odds of BP testing (aOR = 0.10, p < 0.001), but not BP control. Compared to pre-pandemic telemedicine use, pandemic period telemedicine use was associated with lower odds of HbA1c and BP monitoring. Discussion Telemedicine use was associated with lower odds of HbA1c monitoring for adults with type 2 diabetes and lower odds of BP testing for adults with type 2 diabetes and/or hypertension. Conclusion As telemedicine continues to be used for diabetes and hypertension care, remote monitoring, standing orders, and community pharmacy partnerships may be necessary supplements to telemedicine to assure high quality care, especially when in-person care options are limited.

show abstract

Blood pressure drive-through: An innovative way to meet patient care needs during a pandemic

Cited by 3 publications

References 9 publications

Telemedicine Use and Decrements to Type 2 Diabetes and Hypertension Care during the COVID-19 Pandemic

Telemedicine Use and Decrements to Type 2 Diabetes and Hypertension Care during the COVID-19 Pandemic

Pandemic stimulates a variety of telepharmacy applications: Considerations for implementation, sustainability, and future directions

Telemedicine use and decrements to type 2 diabetes and hypertension care during the COVID-19 pandemic

Contact Info

Product

Resources

About